0001805698-22-000001.txt : 20220113 0001805698-22-000001.hdr.sgml : 20220113 20220113113952 ACCESSION NUMBER: 0001805698-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220113 DATE AS OF CHANGE: 20220113 EFFECTIVENESS DATE: 20220113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EIKONOKLASTES THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001805698 IRS NUMBER: 843230045 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-429236 FILM NUMBER: 22528319 BUSINESS ADDRESS: STREET 1: 981 HILL STREET CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 206-332-1394 MAIL ADDRESS: STREET 1: 981 HILL STREET CITY: CINCINNATI STATE: OH ZIP: 45202 D 1 primary_doc.xml X0708 D LIVE 0001805698 EIKONOKLASTES THERAPEUTICS, INC. 2356 Park Avenue Unit 17 CINCINNATI OH OHIO 45206 (513) 549-6484 DELAWARE None None Corporation true 2019 Bruce Halpryn 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Executive Officer Director Samuel Lee 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Executive Officer Director Kenneth Morand 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Director Thomas Finn 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Director Neel Patel 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Director Pharmaceuticals Decline to Disclose 06b false 2021-12-31 false true true true false 0 7000000 2800000 4200000 false 1 0 0 0 false EIKONOKLASTES THERAPEUTICS, INC. /s/ Bruce Halpryn Bruce Halpryn Chief Executive Officer 2022-01-12